Folks, Vericel announced today that it received FDA Fast Track designation for its ixmyelocel‑T product for treatment of advanced heart failure due to dilated cardiomyopathy.
So why am I posting this news about Vericel on this board?
Let's compare Mesoblast to Vericel.
Back in April 2016, Vericel's ixmyelocel‑T product failed to meet it's secondary endpoints of heart-pumping efficiency and six-minute walking distance in the Phase 2b trial.
You read that right - it FAILED to meet it's secondary endpoints. And that was in the Phase 2b trial.
Plus, ixmyelocel‑T is autologous, which means it takes a patient's own stem cells.
As opposed to allogeneic, which is Mesoblast's products. Lookup the comparison advantages of allogeneic vs. autologous especially with respect to mass commercialization and ready, off-the-shelf availability.
Mesoblast's CHF therapy is light years ahead of Vericel's in its efficacy and commercial viability.
And Mesoblast is way past Phase 2 in CHF.
So. The. FDA. Just. Granted. Vericel. Fast. Track. Designation for its ixmyelocel‑T product.
Over and out.
Tick, tock, tick, tock..............
- Forums
- ASX - By Stock
- MSB
- Heart Failure
Heart Failure
-
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B |
Open | High | Low | Value | Volume |
$1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 61090 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 239558 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 61090 | 1.015 |
1 | 700 | 1.010 |
9 | 123952 | 1.005 |
34 | 516697 | 1.000 |
1 | 25000 | 0.995 |
Price($) | Vol. | No. |
---|---|---|
1.030 | 17500 | 1 |
1.035 | 54000 | 2 |
1.040 | 41250 | 2 |
1.045 | 68050 | 4 |
1.050 | 45395 | 3 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online